We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

50 hedge funds and large institutions have $440M invested in Tenaya Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 9

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

6% more funds holding

Funds holding: 47 → 50 (+3)

4.81% more ownership

Funds ownership: 85.65% → 90.46% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

34% less capital invested

Capital invested by funds: $668M → $440M (-$228M)

Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
22
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.73M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$6.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.67M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.68M
5
Northern Trust
Northern Trust
Illinois
+$1.11M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$2.61M
2
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
-$269K
3
Morgan Stanley
Morgan Stanley
New York
-$226K
4
UBS Group
UBS Group
Switzerland
-$35.4K
5
Citigroup
Citigroup
New York
-$34.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$111M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$72.9M +$5.67M +468,276 +8%
CC
3
Casdin Capital
New York
$42.3M – – –
RCM
4
RA Capital Management
Massachusetts
$41.8M – – –
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$35.7M +$459K +37,899 +1%
RI
6
RTW Investments
New York
$29M – – –
BlackRock
7
BlackRock
New York
$28.6M +$6.73M +555,928 +30%
Vanguard Group
8
Vanguard Group
Pennsylvania
$12.8M +$6.4M +528,845 +95%
AI
9
Alphabet Inc
California
$10.8M – – –
EC
10
Euclidean Capital
New York
$10.8M – – –
HMC
11
Harvard Management Company
Massachusetts
$7.93M – – –
DTC
12
Deep Track Capital
Connecticut
$6.44M -$2.61M -215,394 -28%
CC
13
Commodore Capital
New York
$6.05M – – –
SG
14
StepStone Group
California
$5.44M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.34M +$1.68M +139,078 +61%
State Street
16
State Street
Massachusetts
$3.48M +$972K +80,318 +37%
Northern Trust
17
Northern Trust
Illinois
$2.73M +$1.11M +91,586 +65%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$864K +$408K +33,726 +85%
Charles Schwab
19
Charles Schwab
California
$810K +$401K +33,161 +93%
TD Asset Management
20
TD Asset Management
Ontario, Canada
$726K +$319K +26,366 +75%
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$609K +$632K +52,219 New
N
22
Nuveen
North Carolina
$564K +$255K +21,031 +68%
JRP
23
Jasper Ridge Partners
California
$523K – – –
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$454K +$466K +38,516 New
WP
25
Woodline Partners
California
$443K +$455K +37,568 New
1
2 3

TNYA Hedge Fund Activity: Q1 2022 in Review

50 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2022, worth a combined $440M — down 34% from $668M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TNYA positions and 4 closed out — a net gain of 3 holders — while 22 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $6.73M. The largest seller was Deep Track Capital, cutting an estimated $2.61M.

  • 50 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2022, up from 47 in Q4 2021.
  • Funds reported $440M of Tenaya Therapeutics stock for Q1 2022, down 34% quarter-over-quarter.
  • 7 funds opened new Tenaya Therapeutics positions in Q1 2022 and 4 closed out, a net change of +3 holders.
  • The largest Tenaya Therapeutics buyer in Q1 2022 was BlackRock, an estimated $6.73M added.
  • The largest Tenaya Therapeutics seller in Q1 2022 was Deep Track Capital, an estimated $2.61M sold.

Based on aggregated 13F filings for Q1 2022.